CzbnAuto® Pdx1 Autologous Pancreatic Stem Cells
Product Specifications
| ID | Product Specifications | Product Name |
|---|---|---|
| Czbn-ASC006 | 0.1-2×10⁸ | CzbnAuto® Autologous Pancreatic Stem Cells |
Stem Cell Attributes
Tissue-specific stem cells.
Core Features
Directed differentiation
Differentiate into pancreatic endocrine cells (β, α, and δ cells) as well as exocrine acinar cells and ductal epithelial cells.
Glucose homeostasis regulation
Differentiated pancreatic β cells synthesize and release insulin to regulate glucose metabolism in response to blood sugar changes, while α cells secrete glucagon.
Pancreatic injury repair
Activated after pancreatic tissue injury, it replenishes damaged islet and ductal cells to rebuild the pancreatic epithelial structure.
Transform Application Research Directions
The following content is based on the biological characteristics of autologous pancreatic stem cells and publicly available research, intended for educational purposes only and not as medical advice. Related clinical applications must be conducted in accordance with applicable laws and regulations at qualified medical institutions.
Islet β-cell replacement
Research focuses on repairing damaged pancreatic β cells by differentiating them into functional ones, restoring insulin secretion and blood glucose regulation. This explores cell replacement therapies for type 1 diabetes and certain cases of type 2 diabetes.
Islet α/δ cell replacement
Differentiates into pancreatic α cells (secreting glucagon) and δ cells (secreting somatostatin), helping to restore overall islet endocrine function and maintain blood glucose balance.
Why Choose Chunzhu: The Century-Long Life Bank
Third-generation iPSC small-molecule transdifferentiation technology derived from Nobel Prize-winning research
- No gene editing involved, ensuring greater safety.
- Preparation of Autologous Pancreatic Stem Cells from Blood Cell Conversion
- Capable of pancreatic lineage-directed differentiation, tailored for blood glucose health management.
Six Core Advantages
- Draw 80-150 ml of blood; complete library construction within 6-10 days.
- Autologous cell source with low risk of immune rejection and no gene editing involved.
- Store for all ages; produce functional cells on demand
Empowering the Human Genetic Resources Platform
- Platform inbound management, end-to-end sample monitoring and traceability
- Companion AI health simulation and clinical reference plans
Cooperative Consortium of the Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences
- Sync cutting-edge research findings
- Accelerate technology iteration and clinical research advancement
End-to-end workflow: Preparation · Storage · Tertiary Hospital Clinical Integration
- Beyond just storing cells, we enable seamless access and usage.
- Support future clinical translation and implementation
Three steps to storage
Blood Collection and Sampling
80-150ml blood sample collection
GMP Laboratory Library Preparation
Cell preparation and library construction completed in 6-10 days
-196°C Liquid Nitrogen Long-Term Deep-Freeze Storage
Long-term storage and on-demand production of targeted functional cells
This page provides educational information on stem cell science and our company's R&D directions. It does not constitute medical advice or a guarantee of treatment outcomes. For specific applications, please follow the guidance of qualified healthcare professionals.